These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29710211)

  • 1. Addressing Financial Barriers to Enrollment in Clinical Trials.
    Largent EA; Lynch HF
    JAMA Oncol; 2018 Jul; 4(7):913-914. PubMed ID: 29710211
    [No Abstract]   [Full Text] [Related]  

  • 2. Should children be financially compensated for their participation in research studies? Con.
    De Santis J
    MCN Am J Matern Child Nurs; 2007; 32(6):335. PubMed ID: 17968212
    [No Abstract]   [Full Text] [Related]  

  • 3. Should children be financially compensated for their participation in research studies? Pro.
    Lobo ML
    MCN Am J Matern Child Nurs; 2007; 32(6):334. PubMed ID: 17968211
    [No Abstract]   [Full Text] [Related]  

  • 4. Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.
    Nipp RD; Lee H; Powell E; Birrer NE; Poles E; Finkelstein D; Winkfield K; Percac-Lima S; Chabner B; Moy B
    Oncologist; 2016 Apr; 21(4):467-74. PubMed ID: 26975867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reimbursing Patients for Participation in Cancer Clinical Trials.
    Unger JM; Fleury ME
    JAMA Oncol; 2019 Jul; 5(7):932-934. PubMed ID: 31169875
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinton: Medicare to pay for clinical trials.
    Tieman J
    Mod Healthc; 2000 Jun; 30(24):8-9. PubMed ID: 11183501
    [No Abstract]   [Full Text] [Related]  

  • 7. Payment of trial participants can be ethically sound: moving past a flat rate.
    Koen J; Slack C; Barsdorf N; Essack Z
    S Afr Med J; 2008 Dec; 98(12):926-9. PubMed ID: 19374064
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project.
    Levitan B; Getz K; Eisenstein EL; Goldberg M; Harker M; Hesterlee S; Patrick-Lake B; Roberts JN; DiMasi J
    Ther Innov Regul Sci; 2018 Mar; 52(2):220-229. PubMed ID: 29714515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis.
    Colon-Otero G; Smallridge RC; Solberg LA; Keith TD; Woodward TA; Willis FB; Dunn AN
    Cancer; 2008 Feb; 112(3):447-54. PubMed ID: 18085590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Surveys identify barriers to participation in clinical trials.
    Wagle N; Goldman DP; Kilgore M
    J Natl Cancer Inst; 2001 Feb; 93(3):238-9. PubMed ID: 11158194
    [No Abstract]   [Full Text] [Related]  

  • 11. Third party reimbursement for participation in cancer clinical trials: a proposal for legislation.
    Plaue GM
    J Contemp Health Law Policy; 2000; 16(2):305-54. PubMed ID: 10921232
    [No Abstract]   [Full Text] [Related]  

  • 12. Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.
    Wong YN; Schluchter MD; Albrecht TL; Benson AB; Buzaglo J; Collins M; Flamm AL; Fleisher L; Katz M; Kinzy TG; Liu TM; Manne S; Margevicius S; Miller DM; Miller SM; Poole D; Raivitch S; Roach N; Ross E; Meropol NJ
    J Clin Oncol; 2016 Feb; 34(5):479-87. PubMed ID: 26700120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 14. Enrollment of patients to clinical trials in haematological cancer in New South Wales: current status, perceived barriers and opportunities for improvement.
    Murray P; Kerridge I; Tiley C; Catanzariti A; Welberry H; Lean C; Sinclair S; Bishop J; Bradstock K
    Intern Med J; 2010 Feb; 40(2):133-8. PubMed ID: 19220557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Free of charge participation of patients in clinical trials].
    Comisión de Evaluación de Protocolos de Investigación Clínica (CEPIC), Comité de Bioética Dr. Vicente Federico Del Giúdice, Hospital Nacional Prof. Alejandro Posadas
    Medicina (B Aires); 2010; 70(6):582-3. PubMed ID: 21163754
    [No Abstract]   [Full Text] [Related]  

  • 16. [Free of charge participation of patients in clinical trials].
    Moles A
    Medicina (B Aires); 2010; 70(4):395. PubMed ID: 20679067
    [No Abstract]   [Full Text] [Related]  

  • 17. Women's reasons for participation in a clinical trial for menstrual pain: a qualitative study.
    Blödt S; Witt CM; Holmberg C
    BMJ Open; 2016 Dec; 6(12):e012592. PubMed ID: 27965251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding and addressing barriers to recruitment.
    Redmond JL
    Am J Manag Care; 2014 Mar; 20(5 Spec No.):E13. PubMed ID: 25618627
    [No Abstract]   [Full Text] [Related]  

  • 19. Surveys identify barriers to participation in clinical trials.
    Finn R
    J Natl Cancer Inst; 2000 Oct; 92(19):1556-8. PubMed ID: 11018085
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
    Lim C; Sung M; Shepherd FA; Nouriany N; Sawczak M; Paul T; Perera-Low N; Foster A; Zawisza D; Feld R; Liu G; Leighl NB
    J Thorac Oncol; 2016 Jan; 11(1):79-84. PubMed ID: 26762742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.